CD79A and COVID-19: In fact, ocular anti-SARS-CoV-2 IgAs were detected in 10/28 (35.7%) of the enrolled COVID-19 patients, whereas only one control subject belonging to the sanitary staff subgroup exhibited a weak positivity for the presence of ocular IgA.